775 — CK Life Sciences Intl (Holdings) Share News
0.000.00%
Last trade - 00:00- HK$4.90bn
- HK$11.34bn
- HK$5.41bn
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development
Brief: Dogwood Therapeutics, Inc. Announces Financing of up to $26.8 Million to Progress Halneuron® Through Phase 2b Development
Brief: Ck Life Sciences Intl Says Unit Agrees To Sell 100% Membership Interests In ABCJ, LLC, For $125 Million
Brief: CK Life Sciences Intl Posts HY Revenue HK$2.61 Billion
CK Life Sciences drops most in three months on H1 loss forecast
Brief: CK Life Sciences Intl (Holdings) Expects Around HK$150 Million Loss For HY
Factbox: CK Hutchison: Global conglomerate caught in US-China trade spat
CK Life hits 17-month peak on patent application for cancer vaccines
Brief: Ck Life Sciences Intl Says Trading In Shares Of Co Halted
Brief: HKEX Says Trading In Shares Of CK Life Sciences Intl Halted From April 10
Factbox: CK Hutchison: a global conglomerate caught in US-China trade spat
Brief: CK Life Sciences Intl Posts FY Revenue HK$5.52 Billion
Dogwood Therapeutics climbs after shareholder swaps debt for equity
Brief: CK Life Sciences Intl Sees Loss Attributable Of HK$126.6 Million For Year
Brief: CK Life Sciences Intl Says Unit To Sell Pharmagesic (Holdings)
Brief: Ck Life Sciences Intl Says U.S. FDA Granted Fast Track Designation